Oral Low-molecular Weight Hyaluronic Acid in the Treatment of Atrophic Vaginitis

NCT02014428 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2013-12-18

No results posted yet for this study

Summary

To evaluate the effectiveness of low molecular weight hyaluronic acid oral tablets for the treatment of atrophic vaginitis.

Conditions

  • Atrophic Vaginitis

Interventions

DIETARY_SUPPLEMENT

Hyaluronic acid

DRUG

Placebo

Sponsors & Collaborators

  • AGUNCO Obstetrics and Gynecology Centre

    lead OTHER

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Primary Completion
2013-04-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02014428 on ClinicalTrials.gov